BMY241220P38000
- 0.04
- 0.000.00%
Bristol-Myers Squibb Newsroom
Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
Express News | Century Therapeutics - Termination Effective March 12, 2025
Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics
Express News | Bristol-Myers Squibb Co Files for Mixed Shelf; Size Not Disclosed - SEC Filing
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Bristol-Myers Squibb Hits 4-week Low
Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Bristol-Myers Squibb To Go Ex-Dividend On January 3rd, 2025 With 0.62 USD Dividend Per Share
December 11th (Eastern Time) - $Bristol-Myers Squibb(BMY.US)$ is trading ex-dividend on January 3rd, 2025.Shareholders of record on January 3rd, 2025 will receive 0.62 USD dividend per share on
Bristol-Myers Squibb Boosts Quarterly Dividend $0.02 to $0.62 a Share, Payable Feb. 3 to Investors of Record Jan. 3
Press Release: Bristol Myers Squibb Announces Dividend Increase
Bristol Myers Squibb Announces Dividend Increase >BMY
Berenberg Bank Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $60
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
BofA Restarts Coverage of 11 Large-cap Biopharmas
Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell?
B of A Securities Reinstates Neutral on Bristol-Myers Squibb, Announces $63 Price Target
Bristol-Myers Squibb Analyst Ratings